Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Imipenem”

65 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 65 results

Testing effectiveness (Phase 2)Study completedNCT00515034
What this trial is testing

A Safety and Tolerability Study of Doripenem in Patients With Abdominal Infections or Pneumonia

Who this might be right for
Pneumonia, Ventilator-AssociatedPneumonia, BacterialPneumonia+2 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 146
Not applicableStudy completedNCT01852630
What this trial is testing

Imipenem Versus Cefepime in Spontaneous Bacterial Peritonitis and to Evaluate the Risk Factors for Treatment Failure

Who this might be right for
Spontaneous Bacterial Peritonitis
Institute of Liver and Biliary Sciences, India 175
Early research (Phase 1)Study completedNCT04482569
What this trial is testing

Study to Evaluate Safety, Tolerability, and Pharmacokinetics of XNW4107 Alone or in Combination With Imipenem/Cilastatin

Who this might be right for
Bacterial Infections
Evopoint Biosciences Inc. 88
Not applicableStudy completedNCT05048693
What this trial is testing

Use of New Antibiotics in Sweden

Who this might be right for
Multi-antibiotic Resistance
Uppsala University 41
Post-approval studies (Phase 4)Study completedNCT01489124
What this trial is testing

The Population Pharmacokinetics of Imipenem in Patients With Ventilator-associated Pneumonia

Who this might be right for
Ventilator-Associated Pneumonia
Sutep Jaruratanasirikul 9
Post-approval studies (Phase 4)WithdrawnNCT04785924
What this trial is testing

Imipenem/Cilastatin/Relebactam (IMI/REL) in Treatment of CRE Infections

Who this might be right for
Carbapenem-Resistant Enterobacteriaceae InfectionKPCGram-Negative Bacterial Infections+1 more
Wake Forest University Health Sciences
Not applicableStudy completedNCT00950222
What this trial is testing

Impact of Imipenem With Amikacin Pharmacokinetic and Pharmacodynamic

Who this might be right for
Ventilator Associated Pneumonia
Assistance Publique - Hôpitaux de Paris 70
Early research (Phase 1)Study completedNCT03177720
What this trial is testing

Evaluation of Innovative Tools in Development of Antibiotics

Who this might be right for
Pneumonia
Medical University of Vienna 10
Large-scale testing (Phase 3)Study completedNCT03969901
What this trial is testing

Safety, Tolerability, Efficacy and Pharmacokinetics of Imipenem/Cilastatin/Relebactam (MK-7655A) in Pediatric Participants With Gram-negative Bacterial Infection (MK-7655A-021)

Who this might be right for
Suspected or Documented Gram-negative Bacterial Infection
Merck Sharp & Dohme LLC 115
Large-scale testing (Phase 3)Ended earlyNCT00589693
What this trial is testing

To Compare Safety and Efficacy of Doripenem Versus Imipenem-Cilastatin in Patients With Ventilator-Associated Pneumonia

Who this might be right for
Ventilator-Associated Pneumonia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 274
Not applicableUnknownNCT05285046
What this trial is testing

Phenotypic Profile and Molecular Mechanism of Resistance in Carbapenemase-producing Enterobacterales and Pseudomonas Aeruginosa Isolates From Brazilian Hospitals: Implications for the Introduction of IMIPENEM-RELEBACTAM

Who this might be right for
Bacterial InfectionsAntibiotic Resistant Infection
D'Or Institute for Research and Education 250
Early research (Phase 1)Study completedNCT04493151
What this trial is testing

Imipenem/Cilastatin/Relebactam PK in ECMO

Who this might be right for
Sepsis
Joseph L. Kuti, PharmD 8
Post-approval studies (Phase 4)Study completedNCT00871104
What this trial is testing

Fosfomycin Plus Imipenem for Treatment of Infective Endocarditis

Who this might be right for
Infective Endocarditis
Juan A. Arnaiz 50
Not applicableUnknownNCT04196608
What this trial is testing

In Vitro Activity of Ceftolozane/Tazobactam and Imipenem/Relebactam in Clinical Isolates of Pseudomonas Aeruginosa and Enterobacterales Collected From Hematology and Oncology Patients

Who this might be right for
Ceftolozane/TazobactamImipenem/RelebactamHematology and Oncology
Emilio Bouza 1,005
Post-approval studies (Phase 4)Study completedNCT01379157
What this trial is testing

Pharmacodynamics Study of Imipenem in Patients With Ventilator Associated Pneumonia

Who this might be right for
Ventilator Associated Pneumonia
Prince of Songkla University 8
Not applicableUnknownNCT03897582
What this trial is testing

Beta-Lactams Dosing In Pneumonia in ICU in Patients Treated by Continuous Renal Replacement Therapy: the BLIPIC Study

Who this might be right for
Beta-lactamContinuous Renal Replacement TherapyPneumonia+1 more
Centre Hospitalier de Valenciennes 65
Post-approval studies (Phase 4)UnknownNCT01297842
What this trial is testing

Ertapenem Versus Meropenem/Imipenem for ESBL+ Gram-negative Infections

Who this might be right for
Drug Safety
Mahidol University 100
Early research (Phase 1)Study completedNCT04147221
What this trial is testing

Imipenem-Relebactam Pharmacokinetics in Augmented Renal Clearance

Who this might be right for
Sepsis
Hartford Hospital 9
Large-scale testing (Phase 3)Study completedNCT00080496
What this trial is testing

Study Evaluating Tigecycline Versus Imipenem/Cilastatin in Hospital-Acquired Pneumonia

Who this might be right for
Bacterial Pneumonia
Wyeth is now a wholly owned subsidiary of Pfizer 430
Testing effectiveness (Phase 2)Ended earlyNCT01381549
What this trial is testing

GSK2251052 in Complicated Urinary Tract Infection

Who this might be right for
Infections, Urinary Tract
GlaxoSmithKline 20
Next Page